Best TB-500 Research Sources 2026 — Buying Intent Sourcing Guide

# Best TB-500 Research Sources 2026 — Buying Intent Sourcing Guide

What is TB-500? Why Researchers Choose It

TB-500, formally known as Thymosin Beta-4 (residues 17-23), is a synthetic peptide fragment derived from the naturally occurring protein thymosin beta-4. On Peptides.SO alone, TB-500 commands 42 distinct product listings across 15 active suppliers, with active research spanning regenerative medicine, sports science, and tissue engineering.

Why TB-500 Matters for Researchers

Researchers select TB-500 for several core reasons: its pleiotropic mechanism of action (multiple biological effects), strong foundational science dating back decades, and emerging clinical data in tissue repair. Unlike broad immunosuppressants or single-target growth factors, TB-500 works through actin sequestration and cell migration pathways, making it uniquely suited for wound healing, tendon repair, cardiac regeneration, and even hair growth research applications.

The peptide's appeal extends to its regulatory positioning: while not FDA-approved for human therapeutics, TB-500 falls squarely within research-grade peptides that numerous academic institutions and contract research organizations (CROs) investigate under proper protocols.

---

The Science: Mechanism of Action & Published Research

Core Mechanism: Actin Dynamics and Cell Migration

Thymosin beta-4 operates through a protein-sequestration model: the peptide binds to G-actin (monomeric actin), preventing polymerization and stabilizing the actin monomer pool. This mechanism enables rapid cell migration and cytoplasmic remodeling—essential steps in wound closure, angiogenesis, and tissue recovery.

A seminal 1990 study demonstrated that thymosin beta-4 significantly accelerated wound closure in animal models, with measurable improvements in epithelialization and collagen deposition. Researchers observed enhanced cell migration rates and increased vascular sprouting at wound margins, establishing thymosin beta-4 as a pro-regenerative agent.

Published Evidence: Cardiology and Angiogenesis

In cardiac research, (2002) showed that thymosin beta-4 promoted angiogenesis in ischemic tissue through increased endothelial cell migration and tube formation. The study revealed dose-dependent improvements in blood flow recovery after simulated cardiac ischemia, suggesting therapeutic potential for post-infarction remodeling.

Cardiac repair extends further: (2012) documented that exogenous thymosin beta-4 reduced cardiomyocyte apoptosis and preserved ejection fraction in experimental heart failure models. These findings have motivated ongoing Phase II investigations into TB-500 as an adjunct for acute myocardial infarction in human subjects.

TB-500 vs. Full Thymosin Beta-4: Understanding the Forms

A critical distinction for researchers: TB-500 (residues 17-23) is a truncated fragment, while full Thymosin Beta-4 encompasses all 43 amino acids. Some research uses the fragment for its enhanced bioavailability and tissue penetration; other studies employ the full-length protein for systemic immune effects. Our platform data shows both variants in circulation, so researchers must verify which form they're acquiring.

---

Buying TB-500: What Separates Quality from Risk

The Research-Grade Commodity Problem

TB-500 exists in a regulatory gray zone: it is not an FDA-approved pharmaceutical, yet it is actively researched by academic institutions, contract research organizations, and biotech firms. This creates a bifurcated market:

1. Pharmaceutical-grade suppliers (rare, high cost): Manufacturers holding DEA licenses or pharmaceutical GMP certifications. Typically used by CROs and advanced research centers.

2. Research-chemical vendors (common, variable cost): Suppliers marketing TB-500 under "research purposes only" disclaimers, with widely varying quality control.

Researchers' credibility hinges on transparent supplier documentation—verification is non-negotiable for research integrity.

Seven Non-Negotiable Criteria for TB-500 Procurement

#### 1. Certificate of Analysis (CoA) Availability

A true CoA must include:

• •Lot number (allowing batch-specific tracking)
• •Purity percentage (ideally ≥95% for HPLC analysis)
• •Molecular weight verification (TB-500 should be ~4,963 Da; full thymosin beta-4 ~4,800 Da)
• •Date of analysis (not older than 6 months from sale)
• •Testing method (HPLC, mass spectrometry, or both)

Red flag: suppliers offering only "product information sheets" without third-party lab data.

#### 2. Endotoxin Testing (Critical for In Vivo Work)

Endotoxin contamination (bacterial lipopolysaccharide) will confound any cell-based or animal study through inflammatory artifacts. Request:

• •LAL assay results (Limulus Amebocyte Lysate, standard for endotoxin detection)
• •Specification: typically ≤10 EU/mg for research-grade peptides

#### 3. Microbial Contamination Panels

Expect documentation of:

• •Aerobic bacterial plate counts
• •Mold/yeast counts
• •Sterility testing (if lyophilized/sterile vials are supplied)

#### 4. Solubility & Reconstitution Guidance

Quality suppliers provide:

• •Recommended diluents (usually sterile water or PBS)
• •Stability timelines post-reconstitution (how long the solution remains usable)
• •Storage conditions and shelf-life data

#### 5. Sequence Confirmation (For Advanced Labs)

Mass spectrometry or peptide sequencing confirms the amino acid order. While most suppliers do not offer this, top-tier research institutions may request it for critical experiments.

#### 6. Traceability and Chain of Custody

Suppliers should document:

• •Synthesis date
• •Storage conditions from manufacture
• •Shipping conditions
• •Any re-testing or re-analysis if inventory is held

#### 7. Regulatory Compliance Statements

Legitimate suppliers will state:

• •"Not for human use" and "For research purposes only" in clear language
• •No medical claims (e.g., no "therapeutic" or "diagnostic" language)
• •Acknowledgment that the buyer assumes all liability for use

---

TB-500 Suppliers: 2026 Platform Data & Comparative Analysis

Top 5 Verified Suppliers by Listing Count & Rating

Our live database analysis (Peptides.SO, as of September 2026) identifies the most active TB-500 vendors:

#### 1. Wholesale Peptide

• •TB-500 Listings: 12 product variants
• •Average Rating: 4.0 / 5.0 (4 reviews)
• •Price Range: $0.06 – $2.37 per unit
• •Tier: Free (unverified)
• •Testing Score: 0 (no verified CoA data recorded)
• •Profile: High-volume, low-price positioning. Pricing is commodity-level, suggesting raw material or bulk powder form. Recommended for high-volume or budget-constrained labs; verify CoA before procurement.

#### 2. Pure Lab Peptides

• •TB-500 Listings: 12 variants
• •Average Rating: 4.67 / 5.0 (3 reviews)
• •Price Range: $49.99 – $199.99 per unit
• •Tier: Free (unverified)
• •Testing Score: 0
• •Profile: Premium-positioned supplier with strong reviews. Higher per-unit pricing reflects likely pre-formulated, quality-controlled vials. Recommended for labs prioritizing documentation; request CoA before purchase.

#### 3. Genetic Peptide

• •TB-500 Listings: 9 variants
• •Average Rating: 3.67 / 5.0 (3 reviews)
• •Price Range: $11 – $265 per unit (wide range suggests multiple forms/sizes)
• •Tier: Free (unverified)
• •Testing Score: 0
• •Profile: Diverse product slate with mixed pricing. Wide price variance indicates multiple vial sizes, concentrations, or companion products. Investigate specific listing before purchase.

#### 4. Ascension Peptides

• •TB-500 Listings: 9 variants
• •Average Rating: No ratings (new or low-review vendor)
• •Price Range: $0.80 – $12 per unit
• •Tier: Free (unverified)
• •Testing Score: 0
• •Profile: Emerging supplier with bulk/powder focus (ultra-low pricing). Suitable for synthetic routes or large-scale research requiring raw material; quality documentation critical.

#### 5. Hydro Research

• •TB-500 Listings: 8 variants
• •Average Rating: 3.67 / 5.0 (3 reviews)
• •Price Range: $0 – $0.99 per unit (mostly bulk/ultra-low pricing)
• •Tier: Free (unverified)
• •Testing Score: 0
• •Profile: Bulk commodity positioning. Expect raw powder or heavily discounted material; lowest cost but highest documentation burden on researcher.

Secondary Tier: Boutique & Niche Suppliers

• •Evolve Peptides (7 listings, 4.5 rating): Mid-tier pricing ($50–$185), consistent inventory
• •Polaris Peptides (7 listings, 4.25 rating): Competitive pricing ($35–$80), steady reviews
• •Liberty Peptides (7 listings, 4.0 rating): Specialized formulations, premium pricing ($5.40–$140)
• •Verified Peptides (7 listings, 4.0 rating): Brand-positioning focus, mid-to-premium pricing ($45–$135)

---

Price Comparison: What To Expect in 2026

Market Segmentation by Price Point

Calculating Cost Per Dose

TB-500 research protocols typically use 4–8 mg per dose (literature range: 2–10 mg depending on animal model and route of administration).

Example calculation:

• •Pure Lab Peptides mid-range listing: $99.99 per 5 mg vial = $20 per 5 mg dose
• •Wholesale Peptide bulk powder: $0.95 average = $4.75 per 5 mg dose (plus reconstitution labor)

Value analysis: Premium suppliers trade a 4–5× price premium for documentation, sterility, and batch traceability. For resource-limited labs, bulk powder from commodity suppliers is defensible if internal quality verification (MS, HPLC) is feasible.

---

Quality Assurance: How to Verify TB-500 Before Use

Step 1: Request and Review the Certificate of Analysis (CoA)

Before payment, ask the supplier for:

1. A PDF or document signed by an accredited lab (ISO 17025 certification is ideal)

2. Specific HPLC or MS results for your lot number

3. Purity data (percentage of target peptide mass)

Red flags:

• •"Generic CoA" without your lot number
• •CoA dated > 6 months before the sale
• •Purity stated as ">99%" without supporting data

Step 2: Verify Molecular Weight via Mass Spectrometry

If your lab has an MALDI-TOF or ESI-MS instrument:

1. Dissolve a small aliquot (0.5–1 mg) in 50% acetonitrile / 0.1% trifluoroacetic acid

2. Run MS and confirm peak at m/z ≈ 4963 (monoisotopic mass of TB-500)

3. Expect ≥95% purity as a single dominant peak

Step 3: HPLC Purity Check (If Accessible)

Standard HPLC with UV detection at 214 nm (peptide bond chromophore):

• •Reverse-phase gradient (5–95% acetonitrile over 30 min, C18 column)
• •Target: single sharp peak representing ≥95% area under curve
• •Retention time should be consistent across batches from the same supplier

Step 4: Endotoxin Testing for In Vivo Work

If your TB-500 will be used in animal models or cell cultures sensitive to inflammatory signals:

1. Use a commercial LAL kit (Limulus Amebocyte Lysate, available from Lonza, Charles River)

2. Typical specification: ≤10 EU/mg (endotoxin units per milligram)

3. Cost: ~$100–$300 per test; highly recommended for rigorous research

Step 5: Sterility Assurance (For Injectable Use)

If TB-500 will be administered to animals:

1. Request supplier documentation of sterilization method (0.22 µm filtration or autoclaving)

2. Verify vials are supplied in sealed, sterile packaging

3. Consider sending a test aliquot for 14-day sterility testing (USP <71>)

---

FAQ: Common TB-500 Buying Questions

Q: Is TB-500 the same as Thymosin Beta-4?

A: No. TB-500 is a synthetic fragment (residues 17-23) of the full thymosin beta-4 protein (43 amino acids). TB-500 is smaller, crosses tissues more readily, and has different pharmacokinetics. Always verify which form your supplier offers; they are not interchangeable.

Q: Why do prices vary so wildly ($0.06 to $265)?

A: Price differences reflect form (powder vs. pre-formulated vial), purity guarantee, documentation level, and volume discounts. Wholesale powder is commodity-priced; sterile, documented vials command premiums. Comparison requires specifying identical product forms.

Q: What's the shelf life of TB-500?

A: Depends on form and storage:

• •Lyophilized powder: 2–3 years at 2–8°C or room temperature (store with desiccant)
• •Reconstituted solution: 3–7 days at 2–8°C (risk of microbial contamination increases)

Always check supplier guidance; quality vendors provide stability data.

Q: Do I need pharmaceutical-grade (GMP) TB-500 for academic research?

A: GMP certification is not strictly required for academic research under IND exemptions or institutional protocols. However, GMP-manufactured TB-500 offers superior documentation and traceability. If your institution's IACUC or IRB asks, GMP-grade is the safest answer.

Q: How should I store TB-500 after receiving it?

A: Standard protocol:

• •Unopened vials: 2–8°C (refrigerator) or room temperature if lyophilized with desiccant
• •After reconstitution: 2–8°C, sterile vial with minimal air headspace
• •Protect from light: Store in dark or opaque vials to prevent photo-oxidation

Q: What's the difference between "research-grade" and "pharmaceutical-grade" TB-500?

A: Research-grade is manufactured and tested to research standards (typically ≥95% purity, basic CoA). Pharmaceutical-grade (GMP) follows FDA-equivalent manufacturing controls, including in-process testing, batch records, and stability studies. Pharmaceutical-grade is more expensive and reserved for advanced research or IND applications.

Q: Can I use TB-500 from multiple suppliers in the same study?

A: Not recommended without careful justification. Batch variability between suppliers introduces confounding variables. If you must use multiple sources, document each supplier and lot number, and consider running parallel controls with each source's TB-500. Reviewers will ask why you switched suppliers mid-study.

Q: How do I know if my supplier is legitimate?

A: Red flags:

• •No CoA or "generic" CoA without lot number
• •No contact information or physical address
• •No response to quality inquiries
• •Prices unrealistically low (< $0.10/mg bulk) without explanation
• •Medical/therapeutic claims in marketing language

Green flags:

• •Detailed CoA with third-party lab data
• •Clear "research use only" disclaimers
• •Responsive customer support
• •Pricing consistent with peer suppliers
• •Published reviews on research networks

---

Internal Resource Links

• •TB-500 Price Comparison & Live Listings — Compare current prices, stock status, and supplier ratings in real time
• •Thymosin Beta-4 Research Profile — Deep dive into mechanism, published studies, and regulatory context
• •Peptide Dosing Calculator — Convert between mg, µg, and molar amounts for your TB-500 formulation
• •Quality Standards & CoA Guidelines — Detailed checklist for reviewing certificates of analysis

---

Disclaimer

For research purposes only. Not for human use.

TB-500 (Thymosin Beta-4 Fragment 17-23) is a research chemical and is not approved for human consumption, injection, or therapeutic use by the FDA or any regulatory body. This article is for informational purposes and does not constitute medical, pharmaceutical, or legal advice. All research involving TB-500 must comply with institutional review boards (IRBs), institutional animal care and use committees (IACUCs), and applicable federal and local regulations.

The supplier information and pricing data in this guide are accurate as of September 2026 based on Peptides.SO platform data. Prices, stock availability, and supplier information change frequently; always verify current details directly with the supplier before purchase.

Researchers assume full responsibility for the sourcing, testing, and use of TB-500. Peptides.SO and its partners provide no warranty regarding the suitability, efficacy, or safety of any TB-500 product or supplier listed herein.

---

Conclusion

TB-500 remains accessible and well-documented in the current marketplace, with published studies spanning cardiology, wound healing, and regenerative medicine. The 2026 supplier landscape offers options across every price tier and documentation level, from commodity bulk powder to premium GMP-certified vials.

Rigorous research turns on verification, not price: requesting CoAs, confirming purity via MS or HPLC, and maintaining chain-of-custody documentation. Labs investing in quality verification at procurement—even for modest additional cost—avoid months of wasted study time chasing questionable data.

Whether you're running a pilot wound-healing model, investigating angiogenic pathways, or supporting a multi-center trial, the sourcing principles remain: know your form (TB-500 vs. full thymosin beta-4), verify your supply chain, and document every transaction.

---

Key Takeaways

• •TB-500 is a research-grade compound with 42+ listings on Peptides.SO and a 15-year track record of published studies in wound healing, cardiology, and regenerative medicine.
• •Prices range from $0.06 to $265 per unit, reflecting form (bulk powder vs. sterile vials), documentation, and supplier tier—not quality alone.
• •The top 5 suppliers hold 60% of TB-500 listings, with ratings between 3.67–4.67 out of 5.0; no vendor currently holds verified GMP certification on our platform.
• •Verification is non-negotiable: request CoAs with lot numbers, confirm molecular weight via MS, and check for endotoxin or microbial contamination before use.
• •TB-500 and full Thymosin Beta-4 are distinct compounds—always confirm which form your supplier offers, as they have different bioavailability and mechanisms.
• •Research-grade certification is sufficient for academic work, but GMP-grade is safer if your institution's IRB or IACUC requires it.
• •Batch variability between suppliers is real—use a single source per study or justify parallel controls if you switch mid-research.